Literature DB >> 29704764

Antibody-based vaccine strategies against intracellular pathogens.

Arturo Casadevall1.   

Abstract

Historically, antibody-mediated immunity was considered effective against toxins, extracellular pathogens and viruses, while control of intracellular pathogens was the domain of cellular immunity. However, numerous observations in recent decades have conclusively shown that antibody can protect against intracellular pathogens. This paradigmatic shift has tremendous implications for immunology and vaccine design. For immunology the observation that antibody can protect against intracellular pathogens has led to the discovery of new mechanisms of antibody action. For vaccine design the knowledge that humoral immunity can be effective in protection means that the knowledge acquired in more than a century of antibody studies can be applied to make new vaccines against this class of pathogens.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29704764      PMCID: PMC6245945          DOI: 10.1016/j.coi.2018.04.011

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  55 in total

1.  Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism.

Authors:  Erin E McClelland; André M Nicola; Rafael Prados-Rosales; Arturo Casadevall
Journal:  J Clin Invest       Date:  2010-03-24       Impact factor: 14.808

Review 2.  Evolution of intracellular pathogens.

Authors:  Arturo Casadevall
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

3.  A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.

Authors:  Neha Kothari; Sudeep Kothari; Young Joo Choi; Ayan Dey; David E Briles; Dong Kwon Rhee; Rodney Carbis
Journal:  Vaccine       Date:  2014-12-26       Impact factor: 3.641

4.  A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.

Authors:  James E Galen; Jin Yuan Wang; Jose A Carrasco; Scott A Lloyd; Gabriela Mellado-Sanchez; Jovita Diaz-McNair; Olga Franco; Amanda D Buskirk; James P Nataro; Marcela F Pasetti
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

5.  Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.

Authors:  S J Devi; R Schneerson; W Egan; T J Ulrich; D Bryla; J B Robbins; J E Bennett
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Vaccination with Shigella flexneri 2a conjugate induces type 2a and cross-reactive type 6 antibodies in humans but not in mice.

Authors:  Nahid Farzam; Reut Ramon-Saraf; Yonit Banet-Levi; Liat Lerner-Geva; Shai Ashkenazi; Joanna Kubler-Kielb; Evgeny Vinogradov; John B Robbins; Rachel Schneerson
Journal:  Vaccine       Date:  2017-08-07       Impact factor: 3.641

7.  Identification of protective B cell antigens of Legionella pneumophila.

Authors:  Stefan S Weber; Nicole Joller; Anna Barbara Küntzel; Roman Spörri; Vincent S Tchang; Elke Scandella; Christoph Rösli; Burkhard Ludewig; Hubert Hilbi; Annette Oxenius
Journal:  J Immunol       Date:  2012-06-13       Impact factor: 5.422

8.  Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

Authors:  Andrew J Pollard; Kirsten P Perrett; Peter C Beverley
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

9.  Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.

Authors:  Hong Xin; Sebastian Dziadek; David R Bundle; Jim E Cutler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-25       Impact factor: 11.205

10.  Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction.

Authors:  Tingting Chen; Caroline Blanc; Anke Z Eder; Rafael Prados-Rosales; Ana Camila Oliveira Souza; Ryung S Kim; Aharona Glatman-Freedman; Maju Joe; Yu Bai; Todd L Lowary; Rachel Tanner; Michael J Brennan; Helen A Fletcher; Helen McShane; Arturo Casadevall; Jacqueline M Achkar
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

View more
  5 in total

1.  Capsular glycan recognition provides antibody-mediated immunity against tuberculosis.

Authors:  Tingting Chen; Caroline Blanc; Yanyan Liu; Elise Ishida; Sarah Singer; Jiayong Xu; Maju Joe; Elizabeth R Jenny-Avital; John Chan; Todd L Lowary; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

2.  PNAG-specific equine IgG1 mediates significantly greater opsonization and killing of Prescottella equi (formerly Rhodococcus equi) than does IgG4/7.

Authors:  Joana N Rocha; Lawrence J Dangott; Waithaka Mwangi; Robert C Alaniz; Angela I Bordin; Colette Cywes-Bentley; Sara D Lawhon; Suresh D Pillai; Jocelyne M Bray; Gerald B Pier; Noah D Cohen
Journal:  Vaccine       Date:  2019-01-26       Impact factor: 3.641

Review 3.  PLGA Nanoparticles as an Efficient Platform in Protein Vaccines Against Toxoplasma gondii.

Authors:  Mojgan Allahyari
Journal:  Acta Parasitol       Date:  2022-01-11       Impact factor: 1.440

4.  Pregnancy enables antibody protection against intracellular infection.

Authors:  John J Erickson; Stephanie Archer-Hartmann; Alexander E Yarawsky; Jeanette L C Miller; Stephanie Seveau; Tzu-Yu Shao; Ashley L Severance; Hilary Miller-Handley; Yuehong Wu; Giang Pham; Brian R Wasik; Colin R Parrish; Yueh-Chiang Hu; Joseph T Y Lau; Parastoo Azadi; Andrew B Herr; Sing Sing Way
Journal:  Nature       Date:  2022-06-08       Impact factor: 69.504

5.  Comprehending B-Cell Epitope Prediction to Develop Vaccines and Immunodiagnostics.

Authors:  Salvador Eugenio C Caoili
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.